Freshfields and Gibson Dunn score roles on $5bn Sky Bet sale
Freshfields Bruckhaus Deringer has scored the top role in CVC Capital Partners’ sale of Sky Betting and Gaming to online gaming operator Stars Group for nearly $5bn.
Slaughters and Linklaters lead in bid battle for drug maker Shire
Linklaters is acting for Takeda Pharmaceuticals in the ongoing tussle for Irish drug maker Shire, represented by Slaughter and May.
HSF teams up with SullCrom for Weir’s largest-ever acquisition
Herbert Smith Freehills (HSF) and Sullivan & Cromwell have teamed up to advise FTSE 250 engineering company Weir on its billion-dollar acquisition of US provider Esco.
Freshfields leads for Advent in €2bn Sanofi deal
Freshfields Bruckhaus Deringer is advising Advent International on its potential €2bn deal with French pharmaceuticals company Sanofi.
HSF leads in sale of Devonshire Square to co-work giant WeWork
Herbert Smith Freehills (HSF) has advised private equity firm Blackstone, in its £580m sale of a sizable chunk of prime City real estate, the historic Devonshire Square.
Bakers and Davis Polk lead on billion-dollar sale of cancer drugs unit
Baker McKenzie has advised French pharmaceutical company Servier in its $2.4bn purchase of Shire’s oncology business, while Davis Polk & Wardwell was on hand for the latter.
Slaughters and SullCrom lead as FirstGroup rejects Apollo’s advances
Slaughter and May is representing UK transport company FirstGroup, as it holds its ground in rejecting a takeover approach from American private equity house Apollo Management.
All US line-up as tech giant Avast reveals bumper £3bn IPO
White & Case and Latham & Watkins has advised in a deal set to send shock waves along the London market, as Czech-based cyber security Avast plans to list on the Stock Exchange.
Ropes & Gray wins role for Bridgepoint portfolio company in tech deal
Ropes & Gray has advised legal software company BigHand on its acquisition of legal pricing tool DW Reporting.
Linklaters and Travers Smith lead in largest UK software buyout this year
Linklaters has advised Hg Capital in its investment in software company The Access Group, while Travers Smith represented its current majority shareholder TA Associates. The deal will see Hg take joint ownership of the London-based technology group alongside TA Associates. Linklaters partner Alex Woodward led for Hg on the corporate side, with managing associates Aneeq Durrani and […]
Hogan Lovells wins the top role for Novartis in $9bn pharma deal
Hogan Lovells and Cravath Swaine & Moore have won the top roles on Novartis’ $9bn purchase of Chicago-based gene therapy company AveXis. The deal, in which the Swiss pharmaceutical giant is offering $218 per share for AveXis, is being led by Hogan Lovells Washington DC-based corporate transactions partner Joseph Gilligan who is advising Novartis. He is working alongside New […]
Freshfields joins the fray as Hammerson sets pause button on Intu deal
Freshfields Bruckhaus Deringer is representing French shopping centre giant Klépierre in its eleventh hour bid for its British rival, Hammerson, The Lawyer can reveal.